Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis

2006393 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 65, Issue 7, pp. 889-894

Field-Weighted Citation Impact: 32.09